As TTM Technologies prepares to release its quarterly results, analysts anticipate sustained revenue growth and robust performance in the competitive PCB manufacturing sector.
Amid a volatile tech landscape, Opera Limited (OPRA) presents a compelling, if risky, value proposition. With a profitable core business, a clean balance sheet, and a potentially undervalued stake in African fintech giant Opay, some investors see significant upside despite concerns over revenue concentration and market disruption.
The Malaysian marine construction firm Benalec Holdings Berhad is showing early signs of a financial turnaround, with its key profitability metric moving into positive territory after years of losses. While its return on capital remains modest, the trend suggests improved capital allocation.
While flashy jets and missiles capture public attention, L3Harris Technologies operates in the critical, unseen layers of connectivity and electronic warfare. As global tensions and technological threats evolve, its role as a foundational enabler of next-generation defense systems is driving a compelling investment thesis centered on resilience and information dominance.
Bio-Techne (TECH) gains market attention with the launch of its Cultrex Synthetic Hydrogel, a key innovation for 3D cell research. While the product debut coincides with recent share price strength, longer-term returns tell a more complex story for investors.
Amid a challenging market for biotech, C4 Therapeutics (NASDAQ: CCCC) is drawing investor attention with its targeted protein degradation platform. Backed by industry giants and focused on niche cancers, the clinical-stage company presents a high-risk, high-reward proposition. We examine the bull case and the road ahead.
As AI infrastructure scales, reliability becomes paramount. Credo Technology Group, once a niche connectivity player, is now seeing explosive growth as its solutions become critical to preventing costly failures in hyperscale data centers. With revenue soaring over 270% and margins expanding, the debate is whether Credo is a cyclical beneficiary or the foundational 'toll road' of modern AI computing.
Criteo S.A. (NASDAQ: CRTO), the ad-tech firm, is trading at near-historic low valuations, sparking a debate among value investors. While its legacy business faces well-documented headwinds, its growing Retail Media segment and aggressive capital returns present a potential asymmetric opportunity, according to a bullish thesis gaining traction online.
After years of struggle, Oatly Group AB (OTLY) is showing concrete signs of a sustainable turnaround, posting its first quarterly operating profit in ten years. Strategic moves, including debt restructuring and a key investor stake, are fueling optimism for the oatmilk pioneer's path to profitability.
As new leadership takes the helm, battery innovator Amprius Technologies is pivoting its high-energy-density silicon anode technology from niche aerospace applications toward the mass electric mobility market, backed by a new manufacturing strategy and surging revenue.
Wall Street analysts have revised the price target for Priority Technology Holdings (PRTH) to $11, while maintaining a steady fair value estimate, as the firm navigates a mixed earnings quarter and ongoing ownership developments.
Tenet Healthcare has completed a transaction to fully reclaim Conifer Health Solutions, aiming to supercharge the unit's technology and service expansion. The move consolidates a key revenue platform as Tenet rides a multi-year stock surge.
BioNTech appoints Kylie Jimenez as its first Chief People Officer, a strategic move aimed at building the organizational and cultural backbone for its ambitious transition into a multi-product oncology company by 2030.
As vehicle ownership expenses climb, prospective buyers face a transformed automotive landscape. From shifting pricing models to emerging technologies, here’s how to prepare for your next purchase.
Kforce reports stronger-than-expected Q4 2025 results, citing the highest sequential growth in its tech business since 2022. The company sees early signs of a market recovery, fueled by client demand for flexible talent to tackle AI-driven projects and foundational IT work.
Meta Platforms is hit with a patent infringement lawsuit by Solos Technology, targeting core components of its smart glasses. The legal challenge could disrupt product development and partnerships in a key growth area for the tech giant.
Investment firm Hussman Strategic Advisors has liquidated its entire stake in TG Therapeutics, a move that comes as the biotech's stock lags behind broader market gains despite reporting strong revenue growth for its flagship product.
The Trump administration is preparing to review key data-sharing provisions within the Dodd-Frank Act, a move that could redefine privacy standards between traditional banks and financial technology firms like Venmo and Plaid, and alter the competitive balance of the financial sector.
HubSpot CEO Yamini Rangan acknowledges the breakneck pace of change in tech roles but argues the core value of education—learning how to think and solve problems—remains timeless, even as she guides her own son into the field.
As Palantir Technologies reports a massive surge in U.S. government revenue, CEO Alex Karp publicly defends the company's controversial surveillance platforms, insisting they contain safeguards against overreach. The defense comes amidst growing public and political scrutiny over its contracts with immigration enforcement agencies.
